This might be it, a possible cure to aids
Posted 10/19/2009 @ 9:05:23 am by igoufc.com
Aid's is a growing problem in the world this disease has killed and infected millions, if not not billions in it's 30 years reign. Everybody is affected by this disease one shape or the other, “ Me included.” It's a disease, that took my precious aunt from me. I've decide to change the world by introducing a company called Aethlon Medical, Inc. is a developmental-stage medical device company focused on the applications of the Hemopurifier platform technology, which is designed to reduce the presence of infectious viruses from human blood. Hemopurifier is a candidate therapeutic device to assist in the treatment of a range of viral pathogens. Viral treatment targets include bio terror agents, pandemic threats, human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS) and hepatitis-C virus (HCV). On June 10, 2009, the Company disclosed the primary treatment focus of Hemopurifier would be HCV. The wholly owned subsidiaries of the Company are Aethlon, Inc., Cell Activation, Inc., Syngen Research, Inc. and Hemex, Inc. This company can change the world,” I think people should invest in this company because of this research.
Prague hotels
Aid's is a growing problem in the world this disease has killed and infected millions, if not not billions in it's 30 years reign. Everybody is affected by this disease one shape or the other, “ Me included.” It's a disease, that took my precious aunt from me. I've decide to change the world by introducing a company called Aethlon Medical, Inc. is a developmental-stage medical device company focused on the applications of the Hemopurifier platform technology, which is designed to reduce the presence of infectious viruses from human blood. Hemopurifier is a candidate therapeutic device to assist in the treatment of a range of viral pathogens. Viral treatment targets include bio terror agents, pandemic threats, human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS) and hepatitis-C virus (HCV). On June 10, 2009, the Company disclosed the primary treatment focus of Hemopurifier would be HCV. The wholly owned subsidiaries of the Company are Aethlon, Inc., Cell Activation, Inc., Syngen Research, Inc. and Hemex, Inc. This company can change the world,” I think people should invest in this company because of this research. |
Prague hotels |